Concepedia

Shang-Poa Chang

SC

Statistics

Publications

6

Citations

136

H-Index

6

Active since

1989

Affiliations

Pfizer (United States)(Current)

Shang-Poa Chang is an author at Pfizer (United States) specializing in medicinal chemistry, drug discovery, and life sciences.

Publications per year

1989–2011

6

Publications

6

Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14

Julian Blagg, Mark C. Noe, Lilli A. Wolf‐Gouveia et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 59 citations · Full text

, , +13

Cyclic homopentapeptides 1. Analogs of tuberactinomycins and capreomycin with activity against vancomycin-resistant enterococci and Pasteurella

John P. Dirlam, ANNETTE M. BELTON, N. C. BIRSNER et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 22 citations

, , +12

Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X7 receptor

Chakrapani Subramanyam, Allen J. Duplantier, Mark A. Dombroski et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 20 citations · Full text

, , +13

Cyclic homopentapeptides 2. Synthetic modifications of viomycin

Joe Lyssikatos, Shang-Poa Chang, J. P. Clancy et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 12 citations

, , +10

CP-78,545, a new monocarboxylic acid ionophore antibiotic related to zincophorin and produced by a streptomyces.

John P. Dirlam, ANNETTE M. BELTON, Shang-Poa Chang et al. · The Journal of Antibiotics · 1989 · 12 citations · Full text

, , +7

1–5 of 6